Innovation, Transparency Take Center Stage in China Device Reforms

The GMP Letter
A A
China’s State Council has unveiled new guidelines intended to make the medical devices approval process more science-based and efficient.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00